Evidence map›Paper›PMID 24375254›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Astrocyte elevated gene-1 (AEG-1) shRNA sensitizes Huaier polysaccharide (HP)-induced anti-metastatic potency via inactivating downstream P13K/Akt pathway as well as augmenting cell-mediated immune response.

Jiasheng Zheng, Cong Li, Xia Wu, Mengmeng Liu, Xicai Sun, Yingzhuo Yang, Meijun Hao, Shoupeng Sheng, Yu Sun, Honghai Zhang and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Cancer management and research · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. A Huaier polysaccharide reduced metastasis of human hepatocellular carcinoma SMMC-7721 cells via modulating AUF-1 signaling pathway.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  19. A polysaccharide from Andrographis paniculata induces mitochondrial-mediated apoptosis in human hepatoma cell line (HepG2).Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  20. A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Jiasheng ZhengIntervention Therapy Center of Liver Diseases, Beijing You An Hospital, Capital Medical University, Beijing, 100069, China, jiashengzheng@outlook.com.
Cong Li
Xia Wu
Mengmeng Liu
Xicai Sun
Yingzhuo Yang
Meijun Hao
Shoupeng Sheng
Yu Sun
Honghai Zhang
Jiang Long
Yi Liang
Caixia Hu
Beijing YouAn Hospital · CNCapital Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CNCenter for Life Sciences · CNHarbin Medical University · CNNanyang Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrocyte elevated gene-1 (AEG-1) is an important force in the development and progression of hepatocellular carcinoma (HCC). To extend our study, we examined here the role of AEG-1 in anti-metastatic effects of Huaier polysaccharide (HP) on the human HCC MHCC97-H cell line. AEG-1 shRNA contributed to the anti-proliferation effect of HP on MHCC97-H cells. Furthermore, results of Transwell insert chambers showed that low expression of AEG-1 could effectively facilitate HP to suppress MHCC97-H cell migration and invasion. We achieved this by reducing phosphoinositide 3-kinases (P13K) and phosphorylated Akt (pAkt) expression as well as enhancing natural killer (NK) cell activity. Taken together, our data strongly suggested that AEG-1 shRNA could block the carcinogenesis and progression of MHCC97-H cells and highlight the therapeutic potential of HP in HCC treatment, at least by part, by inhibiting the activation of the PI3K/Akt pathway and enhancing the NK cell-mediated immune response. These findings may provide a new strategy for HCC treatment.

Indexed as

Phosphoinositide-3 Kinase InhibitorsAntineoplastic AgentsCarcinoma, HepatocellularCell Adhesion MoleculesCell Line, TumorHumansKiller Cells, NaturalLiver NeoplasmsMembrane ProteinsNeoplasm MetastasisPhosphatidylinositol 3-KinasesPolysaccharidesProto-Oncogene Proteins c-aktRNA-Binding ProteinsRNA, Small InterferingSignal TransductionAntineoplastic AgentsCell Adhesion MoleculesMembrane ProteinsMTDH protein, humanPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPolysaccharidesProto-Oncogene Proteins c-aktRNA-Binding ProteinsRNA, Small Interfering

Identifiers

PMID24375254
OpenAlexW2155026450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.